As previously reported in AD patients [44], when the lesions were alleviated with the therapies the gene expression levels of inflammatory cytokines including IL-1b, IL-4, IL-6, IL10, and IL-13 and serum IgE levels were significantly decreased, which was followed by histopathological observations [4]. This evidence concerns the gene IL10 and Alzheimer disease.